InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
3
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Watson Robert Eugene, 董事. Director active across 2 companies, notably CEL SCI CORP. In total, 3 reports have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €51k. History available since 6 July 2021. The latest transaction was filed on 25 July 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Watson Robert Eugene
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
2,919 股@ US$6.8533.1% 占其流量Common StockSEC:0001236030-25-000008:0
标准退出：2025年10月23日 (T+90)
20,000 股@ US$1.3960.5% 占其流量Common StockSEC:0001236030-24-000015:0
标准退出：2024年8月6日 (T+90)
1,250 股@ US$8.0016.5% 占其流量Common StockSEC:0001646989-21-000008:0
标准退出：2021年10月4日 (T+90)
3 条申报中的 3 条
About Watson Robert Eugene
Robert Eugene Watson serves as a Director at CEL SCI Corp. As a board member, he participates in overseeing operations and strategic decision-making. His experience in the biotechnology sector is valuable in guiding CEL SCI's activities. Robert Eugene Watson is committed to supporting the company's mission and objectives.
